![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 16, 2021 1:16:13 PM
I am writing to you with exciting news; ABMC is selling the Status COVID-19/Flu A+B combo test. Below and attached are some information on this product; please let me know if you might be interested, have any questions or wish to place an order.
• Status™ COVID-19/FLU A&B is an antigen test for use with nasopharyngeal swab specimens.
• Status™ COVID-19/FLU A&B test has been granted emergency use authorization (EUA) by
the FDA for use at the point-of-care setting. During the duration of the emergency this test
can be performed in a patient care setting that is operating under a CLIA Waiver, Certificate
of Compliance or Certificate of Accreditation.
1 test+ 1 specimen = 3 Results
TM
The additive power of Status COVID-19/Flu A&B
Learn More
• Sensitivity and Specificity
- COVID-19 - Sensitivity 93.9%, Specificity 100%
- Flu A - Sensitivity 91.4%, Specificity 95.7%
- Flu B - Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort
I look forward to your feedback.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM